Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CYD Dengue Vaccine With or Without MMR in Healthy Toddlers in the Philippines
2014-001694-14Phase 2
- Sponsor
- Sanofi
- Start
- May 2014
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Recombinant Protein Vaccines → Recombinant Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of CYD dengue vaccine in dengue fever (2 arms), sponsored by Sanofi. Primary endpoint: Safety and reactogenicity.
02
Drugs
CYD dengue vaccine
03
Conditions
dengue fever
Beyond the preview
Go deeper on 2014-001694-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001694-14.